Psyence Biomedical Ltd. (PBM)

USD 0.47

(5.12%)

Market Cap (In USD)

2.13 Million

Revenue (In USD)

-

Net Income (In USD)

-51.15 Million

Avg. Volume

320 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1.51-945.15
PE
-0.01
EPS
-76.91
Beta Value
-0.425
ISIN
CA74449F1009
CUSIP
-
CIK
1985062
Shares
4527128.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Neil Maresky M.D.
Employee Count
-
Website
https://www.psyence.com
Ipo Date
2021-12-10
Details
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed ISO22000 facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.